Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (9)
- Conference Proceeding (1)
Language
- English (10)
Keywords
- 18F-FDG (2)
- Medizin (2)
- PET (2)
- TKI (2)
- positron emission tomography (2)
- vandetanib (2)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- 68Ga-DOTATATE (1)
- American Thyroid Association (1)
- Atherosclerotic plaque (1)
- BRAF(V600E) mutation (1)
- Cardiovascular risk factors (1)
- Combination (1)
- DWI (1)
- EBRT (1)
- Extraocular eye muscles (1)
- Gehirn (1)
- German population (1)
- Insulin (1)
- Macrophage (1)
- Maus (1)
- Meningioma (1)
- Merkel cell carcinoma (1)
- Metastases (1)
- Molecular imaging (1)
- PET/CT (1)
- PRRT (1)
- Peptide receptor radionuclide therapy (1)
- Positron emission tomography (1)
- Positronen-Emissions-Tomografie (1)
- Radiotherapy (1)
- Rhabdomyosarcoma (1)
- Skelettmuskel (1)
- Somatostatin receptor (1)
- Somatostatin receptor expression (1)
- association (1)
- cancer (1)
- differentiated thyroid cancer (1)
- dissection (1)
- distant metastases (1)
- guidelines (1)
- inconsistencies (1)
- management (1)
- medullary thyroid carcinoma (1)
- papillary (1)
- personalized medicine (1)
- radioiodine therapy (1)
- surgery (1)
- tyrosine kinase inhibitor (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (6)
- Medizinische Klinik und Poliklinik I (3)
- Klinik und Poliklinik für Strahlentherapie (2)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Kinderklinik und Poliklinik (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Medizinische Fakultät (1)
- Neurologische Klinik und Poliklinik (1)
- Pathologisches Institut (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (2)
Background
Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with increasing incidence, aggressive behavior and poor prognosis. Somatostatin receptors (SSTR) are expressed in MCC and represent a potential target for both imaging and treatment.
Methods
To non-invasively assess SSTR expression in MCC using PET and the radiotracers [68Ga]DOTA-D-Phe1-Tyr3-octreotide (DOTATOC) or -octreotate (DOTATATE) as surrogate for tumor burden. In 24 patients with histologically proven MCC SSTR-PET was performed and compared to results of computed tomography (CT).
Results
SSTR-PET detected primary and metastatic MCC lesions. On a patient-based analysis, sensitivity of SSTR-PET was 73% for nodal metastases, 100% for bone, and 67% for soft-tissue metastases, respectively. Notably, brain metastases were initially detected by SSTR-PET in 2 patients, whereas liver and lung metastases were diagnosed exclusively by CT. SSTR-PET showed concordance to CT results in 20 out of 24 patients. Four patients (17%) were up-staged due to SSTR-PET and patient management was changed in 3 patients (13%).
Conclusion
SSTR-PET showed high sensitivity for imaging bone, soft tissue and brain metastases, and particularly in combination with CT had a significant impact on clinical stage and patient management.